📋 Tender Overview
Cannabix Technologies Inc. the Company or Cannabix developer of marijuana breathalyzer devices for law enforcement and the workplace reports that engineers have achieved new much higher levels of resolving power using a new PCB design and the latest mosfet chip technology leading to the highest level of molecular specificity to date with its Cannabix FAIMS Beta 3.2 circuit. The Company also reports the design of a significantly more compact FAIMS circuit board paving the way for a smaller device footprint relative to previous versions enhancing portability. Cannabix is using its FAIMS technology to isolate and detect 9-tetrahydrocannabinol THC a non-volatile compound in breath. The Cannabix FAIMS marijuana breathalyzer device uses ion mobility filtering techniques related to mass spectrometry the gold standard analytical technique for molecular detection. Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of THC - the psychoactive component of marijuana that causes impairment. Rav Mlait CEO stated The Company believes that these latest developments with the Companys FAIMS based detection system open up areas of analytical chemistry that diagnostic fields have been seeking for chemical analysis. Our team has made significant technological strides even under covid constraints over the last number of months. The Company also reports that it has recently participated in an information session highlighting the Companys breath testing technologies with a group of transportation safety policy experts primarily from the northeastern region of the US.